Stay updated on Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check20 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check42 days agoChange DetectedThe study has been terminated early due to recruitment challenges and low likelihood of achieving targeted efficacy, with plans to open Part III. Additionally, the date for results posting has been updated to May 21, 2025.SummaryDifference7%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of RO7296682 with Atezolizumab in Solid Tumors Clinical Trial page.